Rare severe mycotic infections in children receiving empirical caspofungin treatment for febrile neutropenia
AUTOR(ES)
Karapinar, Deniz Yilmaz, Karadas, Nihal, Sivis, Zühal Önder, Yazici, Pinar, Duyu, Muhterem, Metin, Dilek, Karapinar, Bülent, Aydinok, Yeşim
FONTE
Braz J Infect Dis
DATA DE PUBLICAÇÃO
2015-10
RESUMO
ABSTRACTEmpirical antifungal therapy is most often given to patients with leukemia. However breakthrough fungal infections under antifungal therapy are not uncommon. Four children, with hematologic malignant disease developed mycotic breakthrough infections while on empirical caspofungin treatment for a median of 14 (range 11-19) days. Trichosporon asahii was detected in the blood culture of two patients and Geotrichum capitatum in the other two (one patient also had positive cerebrospinal fluid culture). Because the patients' clinical situation worsened, voriconazole was empirically added for two patients three and five days before the agent was detected. The first sterile blood culture was obtained 3-7 days of voriconazole treatment. All patients reached clear cultures but one patient died. One patient with central nervous system infection with G. capitatum had severe neurological sequelae. Very severe fungal infections can occur during empirical caspofungin therapy. Therefore, patients should be followed closely.
Documentos Relacionados
- Coronaviruses in children with febrile neutropenia
- Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres
- Artigo: oral vs. intravenous empirical antimicrobial therapy in febrile neutropenic patients receiving childhood cancer chemotherapy
- Use of biomarkers in the management of febrile neutropenia episodes in children with cancer
- Outpatient therapy for patients with febrile neutropenia